Rang	Name	Position
1	Dr. Peter P. Luo Ph.D.	Co- Founder, Chairman, CEO and President of R&D
2	Mr. Man Kin Tam M.B.A.	CFO & Director
3	Ms. Ling Zhou	Executive Director & Head of Human Resources
4	Dr. Qinghai Zhao Ph.D.	Chief Manufacturing Officer
5	Mr. Mickael Chane-Du	Chief Strategy Officer
6	Ms. Chunfang Gu	Executive Director of Finance
7	Ms. Yan Li M.B.A.	Senior Vice President of Bioinformatics & Information Technology
8	Ms. Xiaohong She	Senior VP & Head of Clinical Operations
9	Dr. Guizhong Liu Ph.D.	Senior Vice President of Early Drug Discovery
10	Mr. Alexander Goergen	VP & Head of Business Development

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HSG Holding Ltd	2,00%	4,57 Mio. USD
2	Squadron Capital Management LLC	1,86%	4,25 Mio. USD
3	Ameriprise Financial Inc	0,91%	2,07 Mio. USD
4	Citadel Advisors Llc	0,76%	1,72 Mio. USD
5	Exome Asset Management LLC	0,73%	1,66 Mio. USD
6	Mill Creek Capital Advisors LLC	0,30%	0,68 Mio. USD
7	Quadrature Capital Limited	0,12%	0,27 Mio. USD
8	Morgan Stanley - Brokerage Accounts	0,10%	0,23 Mio. USD
9	Amvescap Plc.	0,07%	0,16 Mio. USD
10	SmartHarvest Portfolios, LLC	0,06%	0,14 Mio. USD
11	Kamunting Street Cap Management, L.p.	0,06%	0,13 Mio. USD
12	Persistent Asset Partners Limited	0,05%	0,12 Mio. USD
13	Dauntless Investment Group, LLC	0,05%	0,12 Mio. USD
14	Renaissance Technologies Corp	0,05%	0,12 Mio. USD
15	Jane Street Group LLC	0,05%	0,10 Mio. USD
16	Alyeska Investment Group, L.P.	0,03%	0,07 Mio. USD
17	Royal Bank of Canada	0,03%	0,06 Mio. USD
18	Two Sigma Investments LLC	0,02%	0,04 Mio. USD
19	Geode Capital Management, LLC	0,02%	0,04 Mio. USD
20	UBS Group AG	0,01%	0,01 Mio. USD